Fig. 7 | Scientific Reports

Fig. 7

From: TIGAR regulated by HPV E6 is correlated with disease stage, drug sensitivity, and immune microenvironment in cervical cancer

Fig. 7

The sensitivity of TIGAR and common chemotherapy drugs. Based on the drug sensitivity data from the GDSC database, the predicted potential therapeutic agents were (A) 5-Fluorouracil, (B) Bortezomib, (C) GSK2606414, (D) MG-132, (E) Mirin, (F) Oxaliplatin, (G) P22077, (H) PFI3, (I) Podophyllotoxin bromide, (J) Ruxolitinib, (K) SB216763, (L) Tozasertib, (M) Vincristine, (N) Vinorelbine.

Back to article page